32650027|t|Inhibitory potency of 4- substituted sampangine derivatives toward Cu2+ mediated aggregation of amyloid beta-peptide, oxidative stress, and inflammation in Alzheimer's disease.
32650027|a|Cu2+ plays a key role in the pathogenesis of Alzheimer's disease (AD). The dysregulation of Cu2+ can cause neuronal damage and aggravate development of AD. Moreover, a series of 4-substituted sampangine derivatives have been investigated as inhibitors of acetylcholinesterase and beta-amyloid (Abeta) aggregation for the treatment of AD in our previous studies. In the present study, we reported that one of these derivatives SD-1 was able to modulate Cu2+-mediated multiple pathological elements in AD. The high selectivity of SD-1 for Cu2+ over other biologically relevant metal ions was demonstrated by ITC. Western blotting analysis, light-scattering study, DCF-DA assay and paralysis experiment indicated that SD-1 suppressed the formation of Cu2+-Abeta species, alleviated the Cu2+-Abeta species induced neurotoxicity and inhibited the production of ROS catalyzed by Cu2+-Abeta species in SH-SY5Y cells over-expressing the Swedish mutant form of human APP (APPsw SH-SY5Y) and Abeta42 transgenic C elegans (CL2020). Furthermore, SD-1 inhibited the expressions of NO, iNOS, TNF-alpha, IL-1beta and IL-6 induced by Cu2+ in BV2 microglial cells. Collectively, these findings provided valuable insights into the design and development of potent metal-chelating agents for AD treatment.
32650027	37	47	sampangine	Chemical	MESH:C121572
32650027	67	71	Cu2+	Chemical	-
32650027	140	152	inflammation	Disease	MESH:D007249
32650027	156	175	Alzheimer's disease	Disease	MESH:D000544
32650027	177	181	Cu2+	Chemical	-
32650027	222	241	Alzheimer's disease	Disease	MESH:D000544
32650027	243	245	AD	Disease	MESH:D000544
32650027	269	273	Cu2+	Chemical	-
32650027	284	299	neuronal damage	Disease	MESH:D009410
32650027	329	331	AD	Disease	MESH:D000544
32650027	369	379	sampangine	Chemical	MESH:C121572
32650027	432	452	acetylcholinesterase	Gene	43
32650027	471	476	Abeta	Gene	351
32650027	511	513	AD	Disease	MESH:D000544
32650027	603	607	SD-1	Gene	57306
32650027	629	633	Cu2+	Chemical	-
32650027	677	679	AD	Disease	MESH:D000544
32650027	705	709	SD-1	Gene	57306
32650027	714	718	Cu2+	Chemical	-
32650027	752	757	metal	Chemical	MESH:D008670
32650027	839	845	DCF-DA	Chemical	MESH:C029569
32650027	856	865	paralysis	Disease	MESH:D010243
32650027	892	896	SD-1	Gene	57306
32650027	925	929	Cu2+	Chemical	-
32650027	930	935	Abeta	Gene	351
32650027	960	964	Cu2+	Chemical	-
32650027	965	970	Abeta	Gene	351
32650027	987	1000	neurotoxicity	Disease	MESH:D020258
32650027	1033	1036	ROS	Chemical	-
32650027	1050	1054	Cu2+	Chemical	-
32650027	1055	1060	Abeta	Gene	351
32650027	1072	1079	SH-SY5Y	CellLine	CVCL:0019
32650027	1129	1134	human	Species	9606
32650027	1146	1153	SH-SY5Y	CellLine	CVCL:0019
32650027	1159	1166	Abeta42	Gene	351
32650027	1178	1187	C elegans	Species	328850
32650027	1189	1195	CL2020	CellLine	CVCL:K782
32650027	1211	1215	SD-1	Gene	57306
32650027	1249	1253	iNOS	Gene	18126
32650027	1255	1264	TNF-alpha	Gene	21926
32650027	1266	1274	IL-1beta	Gene	16176
32650027	1279	1283	IL-6	Gene	16193
32650027	1295	1299	Cu2+	Chemical	-
32650027	1303	1306	BV2	CellLine	CVCL:0182
32650027	1423	1428	metal	Chemical	MESH:D008670
32650027	1450	1452	AD	Disease	MESH:D000544
32650027	Positive_Correlation	MESH:D020258	351
32650027	Negative_Correlation	MESH:D020258	57306
32650027	Negative_Correlation	MESH:C121572	43
32650027	Negative_Correlation	MESH:C121572	MESH:D000544
32650027	Negative_Correlation	MESH:C121572	351
32650027	Negative_Correlation	351	57306
32650027	Association	MESH:D010243	57306
32650027	Negative_Correlation	MESH:C121572	MESH:D007249
32650027	Negative_Correlation	16193	57306
32650027	Negative_Correlation	18126	57306
32650027	Negative_Correlation	16176	57306
32650027	Negative_Correlation	21926	57306

